Geniposide and Chlorogenic Acid Combination Improves Non-Alcoholic Fatty Liver Disease Involving the Potent Suppression of Elevated Hepatic SCD-1. The gene discussed is SCD; the disease is metabolic dysfunction-associated steatotic liver disease.